How to buy ESSA Pharma (EPIX) shares in the UK

Learn how to easily invest in ESSA Pharma shares.

ESSA Pharma Inc (EPIX) is a leading biotechnology business based in Canada. In the week up to 15 January ESSA Pharma shares plunged 29.87% to a closing position of $9.32. However, over the last 12 months, ESSA Pharma's share price has risen by an impressive 66.88% from $16.88. ESSA Pharma is listed on the NASDAQ. All prices are listed in US Dollars.

How to buy shares in ESSA Pharma

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: EPIX in this case.
  5. Research ESSA Pharma shares. The platform should provide the latest information available.
  6. Buy your ESSA Pharma shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted ESSA Pharma's share price?

Since the stock market crash that started in February 2020, ESSA Pharma's share price has had significant positive movement.

Its last market close was $8.73, which is 38.14% up on its pre-crash value of $5.4 and 191.00% up on the lowest point reached during the March 2020 crash when the shares fell as low as $3.

If you had bought $1,000 worth of ESSA Pharma shares at the start of February 2020, those shares would have been worth $678.11 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,578.65.

ESSA Pharma share price (NASDAQ:EPIX)

Use our graph to track the performance of EPIX stocks over time.

ESSA Pharma shares at a glance

Information last updated 2021-07-09.
Previous close$27.08
Change %4.0251%
Information last updated 2022-01-17.
52-week range$7.42 - $36
50-day moving average$12.5138
200-day moving average$18.2643
Wall St. target price$37.2
Dividend yieldN/A (0%)
Earnings per share (TTM)$-0.956
eToro Free Stocks

Invest in ESSA Pharma shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 20x ESSA Pharma shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £2.07
£415.60 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.03
£414.57 total
Capital at risk
Stake logo £0 £50 £2.07
£415.60 total
Capital at risk
IG Share Dealing logo £0 £250 £9.44
£422.98 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.09
£429.62 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £14.19
£427.73 total
Capital at risk
Fineco logo £0 No minimum £4.14
£417.67 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £14.67
£428.20 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy ESSA Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.


Gross profit TTM $0
Return on assets TTM -16.66%
Return on equity TTM -26.94%
Profit margin 0%
Book value $4.411
Market capitalisation $409.9 million

TTM: trailing 12 months

ESSA Pharma share dividends

We're not expecting ESSA Pharma to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have ESSA Pharma's shares ever split?

ESSA Pharma's shares were split on a 1:20 basis on 24 April 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ESSA Pharma shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for ESSA Pharma shares which in turn could have impacted ESSA Pharma's share price.

Share price volatility

Over the last 12 months, ESSA Pharma's shares have ranged in value from as little as $7.42 up to $36. A popular way to gauge a stock's volatility is its "beta".

EPIX.US volatility(beta: 1.5)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ESSA Pharma's is 1.4957. This would suggest that ESSA Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site